GLTO- Galecto, Inc.

Name: Galecto, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Galecto, Inc. (GLTO) has 6 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. GLTO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Fairmount Funds Management LLC	2.90M	-	-
Other	Hewes L. Becker	264.6K	-	-
Dir	Bruno Julianne	137.0K	-	-
CEO	Schambye Hans T.	2.6K	-	-
Other	Winslow Garrett	2.1K	-	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 9, 2021	Schambye Hans T.	Chief Executive Officer	Buy	4,500	$3.50	$15,750.00	+10.5%	-35.0%	-52.4%
Nov 8, 2021	Freve Jonathan	Chief Financial Officer	Buy	3,000	$3.40	$10,200.00	+60.0%	-32.1%	-43.6%
Aug 18, 2021	Freve Jonathan	Chief Financial Officer	Buy	3,000	$3.92	$11,760.00	+150.0%	-17.0%	-45.2%
Jun 28, 2021	Lindmark Bertil	Chief Medical Officer	Buy	2,000	$5.26	$10,520.00	New	-30.3%	-66.8%
Jun 24, 2021	Schambye Hans T.	Chief Executive Officer	Buy	3,000	$5.11	$15,330.00	+7.5%	-26.3%	-66.7%
Jun 23, 2021	Freve Jonathan	Chief Financial Officer	Buy	2,000	$4.74	$9,480.00	New	-21.8%	-64.6%
Jun 23, 2021	Winslow Garrett	General Counsel	Buy	2,000	$4.80	$9,600.00	New	-21.8%	-64.6%
Nov 2, 2020	Novo Holdings A/s58	10% Owner	Buy	333,333	$15.00	$4,999,995.00	+15.4%	-	-
Nov 2, 2020	Khuong Chau Quang	Director, 10% Owner	Buy	733,333	$15.00	$10,999,995.00	+25.5%	-	-
Nov 2, 2020	Orbimed Advisors LLC67	Director, 10% Owner	Buy	733,333	$15.00	$10,999,995.00	+25.5%	-	-

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC